Abstract: Recently, methods for detecting dangerous traffic conditions from videos using machine learning have been studied to improve the efficiency of road management. Most of these methods detect ...

In the fourth iOS 26.1 beta, Apple added a "Tinted" option that reduces the translucency of Liquid Glass for those who prefer a more opaque look. I saw some comments wondering whether the setting ...

As token buybacks gain popularity in crypto, Amir Hajian, head of research at market making firm Keyrock, warns in a new report that every dollar spent repurchasing tokens is a dollar diverted from ...

A simple relationship test called the “bird theory” is spreading on TikTok as a way to find out if your partner even cares. All you have to do is point out something not particularly interesting, like ...

SUMMIT, N.J., Oct. 21, 2025 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), announced recent data showing that cell-based influenza vaccines offer greater protection in preventing ...

Data presented at IDWeek 2025 alongside additional clinical and validation data, education session on the use of metagenomics in central nervous system infections “Due to its ability to detect a wide ...

Gov. Phil Murphy conditionally vetoed legislation Monday that would require data centers to report their water and electricity use, asking lawmakers to add provisions directing state regulators to ...

Sign up for Chalkbeat’s free weekly newsletter to keep up with how education is changing across the U.S. Charles Longshore distinctly remembers the tipping point ...

Testing inside the fab or packaging house can determine whether a chip or package meets all the functional requirements at time zero, but how that chip behaves in the field during its lifetime and ...

Today’s best artificial intelligence (AI) models sail through the Turing test, a famous thought experiment that asks whether a computer can pass as a human by interacting through text. Some see an ...

GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates, but the Big Pharma’s oncology R&D chief told Fierce to “stay tuned” for the company’s own data. The ...